Skip to main content

Donate Today

Every gift, no matter the size, helps change children’s lives.

Vaccines and autism

Vaccines and autism

Autism has been studied for decades, including its causes. When we don’t understand the cause of a condition, many possible causes are questioned. For autism, people have questioned things that babies are exposed to before birth or in the early months of life. This includes environmental exposures, like use of acetaminophen during pregnancy and receipt of vaccines in the first few months of life. In both cases, many studies have shown these hypotheses to be unsupported by the science. The evidence has not stopped some people from continuing to wonder about them. 

Because autism covers a spectrum of disorders, there will not be a single cause. Some causes of autism that have been identified include:

  • Genetics 
  • Certain viral infections 
  • Parental age 

Keep reading to find out more.  

About autism

Autism represents a spectrum of disorders. Each involves the brain and causes issues with socialization and communication. Some people are more severely affected than others. People with autism can experience a range of behaviors and symptoms, including:

  • Lack of interest in others
  • Resistance to change
  • Insistence on repetition, such as with schedules
  • Hand flapping or body rocking
  • Cognitive disabilities
  • Aggression or self-injury
  • Seizures

Over time, the rates of autism have increased. In 2000, less than 1 in 1,000 children (1 in 150) were diagnosed with autism spectrum disorder (ASD), whereas in 2022, about 32 in 1,000 children (1 in 31) were diagnosed with ASD. These increased rates are alarming, but much of the increase can be explained by factors such as:

  • Increased screening – In 2001, the American Academy of Pediatrics (AAP) provided tools to help clinicians identify children who may be developmentally delayed or if parents had concerns. However, in 2007 they changed the guidance to recommend that every baby be screened for autism between 18 and 24 months of age, even if concerns were not brought to attention. When more screenings are completed, more diagnoses will be made. Likewise, whereas historically, more White children were diagnosed with autism-related conditions, increased screening led to higher levels of diagnoses among other racial and ethnic groups as well.
  • Diagnostic criteria changes – A broader range of conditions is categorized within autism spectrum disorder than historically was included. Likewise, some other diagnoses, such as moderate to severe intellectual disability, have decreased as autism spectrum disorder rates have increased. As educational resources and accommodations are often based on particular diagnoses, ensuring that a child can get the help they need in these settings has also been identified as a factor leading to increased rates of diagnosis.

With this said, scientists and clinicians also point to genetic and environmental factors that could be contributing to a portion of these increases, particularly as understanding of some of the causes of autism has increased. 

Genetics

One of the best ways to determine whether a particular disease or syndrome is genetic is to examine the incidence in identical and fraternal twins. Studies in twins have found that about 60% of the time when one twin is diagnosed with autism, their identical twin is also diagnosed. On the other hand, if the twins are fraternal, the risk to the second twin is the same as for non-twin siblings. If the study is done using a broader definition of autism (i.e., autistic spectrum disorder), these rates rise to about 92% in identical twins and about 10% when the twins are fraternal. Therefore, autism clearly has a genetic basis.

Exposures before birth

Some findings support the notion that autism can result from exposures that occur before birth. For example: 

  • Children exposed to thalidomide during the first or early second trimester were found to have an increased incidence of autism. Thalidomide was a medication that used to be prescribed to pregnant women to treat nausea. However, autism occurred more often in children with ear abnormalities compared with those that had arm or leg abnormalities. Because ears develop before 24 days gestation, and arms and legs develop after 24 days gestation, the risk period for autism following receipt of thalidomide was greater before 24 days gestation. 
  • Rodier and colleagues found evidence for structural abnormalities of the nervous system in children with autism. These abnormalities could only have occurred during development of the nervous system in the womb.
  • Children with congenital rubella syndrome are at increased risk for development of autism. Risk is associated with exposure to rubella before birth but not after birth.

Parental age and maternal health

Studies have demonstrated that older parental age can increase the risk for a child to be diagnosed with autism. Likewise, maternal health factors, such as obesity, diabetes and immune system disorders increase the risk. As with other causes of autism, however, not every child born to a parent with one of these factors will go on to develop autism. 

Timing of first symptoms

Clues to the causes of autism can be found in studies examining when the symptoms of autism are first evident. "Home-movie" studies that took advantage of the fact that many parents take movies of their children during their first birthday (before they have received the measles, mumps, rubella (MMR) vaccine) have been helpful.

Home movies from children who were eventually diagnosed with autism and those who were not diagnosed with autism were shown to developmental specialists who did not know which children were later diagnosed with autism. With a very high degree of accuracy, the specialists were able to identify which children were later diagnosed with autism. The investigators were able to detect subtle symptoms of autism that were present earlier than some parents had suspected. Notably, since the children had not received the MMR vaccine, the vaccination could not have contributed to their later diagnosis. 

For a more detailed understanding of what is known about the causes of autism, check the Autism Speaks website. 

Baby smiling

Vaccines and autism Q&A

Vaccines and autism

Which vaccines or general concerns have been questioned?

  • Measles, mumps, rubella (MMR) vaccine
  • Thimerosal, a mercury-containing ingredient, in vaccines 
  • Too many vaccines

History behind these concerns

The first concern related to autism and vaccines focused on the MMR vaccine. Two studies were cited by those claiming that the MMR vaccine causes autism. Both studies are critically flawed. Both were completed by Andrew Wakefield, a scientist and clinician who was practicing in London at the time. He has since lost his medical license and moved to the U.S., where he continues to promote his unfounded ideas. Keep reading to find out more about each of the studies.

Wakefield’s first study

In 1998, Andrew Wakefield and colleagues published a paper in the journal The Lancet. Wakefield's theory was that the MMR vaccine caused a series of events that led to the development of autism. According to his theory, the vaccine caused intestinal inflammation that enabled proteins harmful to the brain to enter the bloodstream and cause autism. In support of his theory, Dr. Wakefield described 12 children with regressive developmental delays. According to the authors, parents of eight of the children reported symptom onset after receipt of the MMR vaccine. However, the timing of intestinal complaints and receipt of MMR did not follow any specific pattern, and in several cases, the parents couldn’t identify when the intestinal complaints began. 

The Wakefield paper published in 1998 was flawed for two reasons:

  1. About 90% of children in England received MMR at the time this paper was written. Because MMR is administered at a time when many children are diagnosed with autism, it would be expected that most children with autism would have received an MMR vaccine, and that many would have received the vaccine recently. The observation that some children with autism recently received MMR is, therefore, expected. To determine whether MMR causes autism, the rates of autism would need to be compared in both vaccinated and unvaccinated children. This wasn't done.
  2. Although the theory suggested that autism resulted in part from intestinal inflammation, in several cases the timing of the onset of intestinal symptoms could not be determined. In other cases, the intestinal symptoms were observed after, not before, the development of autism-related symptoms.

This study was subsequently retracted. In scientific terms, retraction means that the paper is not part of the scientific record because it was found to be based on scientific misconduct. In this case, the studies were deemed fraudulent and data misrepresented.

Wakefield’s second study

In 2002, Wakefield and co-workers published a second paper examining the relationship between measles virus and autism. The authors tested intestinal biopsy samples for the presence of measles virus from children with and without autism. Seventy-five of 91 children with autism were found to have measles virus in intestinal biopsy tissue as compared with only 5 of 70 patients who didn't have autism. On its surface, this was a concerning result. However, the second Wakefield paper was also critically flawed for the following reasons:

  1. Measles vaccine virus is live and attenuated. After inoculation, the vaccine virus replicates (or reproduces itself) probably about 15 to 20 times. Measles vaccine virus is likely to be taken up by specific cells responsible for virus uptake and presentation to the immune system (termed antigen-presenting cells, or APCs). Because all APCs can travel throughout the body (including to the intestine), it is plausible that a child immunized with MMR would have measles virus detected in intestinal tissues using a sensitive assay. To determine if receipt of MMR vaccine is associated with autism, one must compare children with or without autism, and the groups must be identical in two ways. First, both groups must be matched for immunization status (i.e., receipt of the MMR vaccine). Second, they must be matched for the length of time between receipt of MMR vaccine and the collection of biopsy specimens. Although this information was available to the study authors (and critical to their theory), it was not included in the paper.
  2. Because natural measles virus is still circulating in England, it would have been important to determine whether the measles virus detected in these samples was natural measles virus or vaccine virus. Although methods are available to distinguish these two types of virus, the authors did not do this.
  3. The method used to detect measles virus in these studies was very sensitive. Laboratories that work with natural measles virus (such as the lab where these studies were performed) are at high risk of getting results that are incorrectly positive. No mention is made in the paper as to how this problem was avoided.
  4. As is true for all laboratory studies, the person who is performing the test should not know whether the sample is obtained from a case with autism or without autism (blinding). No statements were made in the methods section to assure that blinding occurred.

After several studies found that the MMR vaccine didn’t cause autism, some people began to wonder whether a mercury-containing ingredient, called thimerosal, used in vaccines to prevent contamination was causing autism. Notably, the MMR vaccine never contained thimerosal, so this concern related to other vaccines. When studies demonstrated that receipt of thimerosal-containing vaccines did not increase the risk for autism, the concern that too many vaccines were causing autism appeared. This concern was also tested, and the data did not support this idea either. 

What the science tells us about vaccines and autism 

Several studies have been performed that disprove the notion that MMR causes autism. While we will only go through a few of the earliest studies in detail here, you can look at the references below or the list of references in this Q&A to quickly realize the massive efforts and resources that scientists put into exploring each of the theories related to vaccines and autism. None were found to link these ideas. 

Numerous, well-designed studies conducted in multiple ways by various researchers on multiple continents evaluating hundreds of thousands of children have not revealed any evidence to suggest that vaccines cause autism. Unfortunately, some poorly constructed studies conducted, or promoted, by people who have chosen to disregard this massive body of evidence are still occasionally put forth as evidence. Sometimes, these people suggest that data have been hidden, but imagine what a huge cover-up that would need to be given that scientists around the world have explored these ideas. The simple truth is that the data do not support these ideas. 

One final note is to be aware that some of these individuals continue to try to design studies that will prove what they want them to prove. This is the opposite of how science should be conducted. Anytime a person is starting with a particular outcome and trying to develop data that supports it, you should consider that a red flag. 

Study #1: Brent Taylor and co-workers

In 1999, Brent Taylor and co-workers examined the relationship between receipt of MMR and development of autism in an excellent, well-controlled study. Taylor examined the records of 498 children with autism or autism-like disorder.

Cases were identified by registers from the North Thames region of England before and after the MMR vaccine was introduced into the United Kingdom in 1988. Taylor then examined the rates and age at diagnosis of autism in vaccinated and unvaccinated children. He found that:

  1. The percentage of vaccinated children was the same in children with autism as compared with other children in the North Thames region.
  2. No difference in the age of diagnosis of autism was found in vaccinated and unvaccinated children.
  3. The onset of symptoms of autism did not occur within two, four or six months of receiving the MMR vaccine.

Study #2: Madsen and colleagues

Another study was performed by Madsen and colleagues in Denmark between 1991 and 1998. The study included 537,303 children. About 82% of children had received the MMR vaccine. The children were identified in the Danish Civil Registration System. Their vaccination status was obtained from the Danish National Board of Health, and those with autism were identified from the Danish Central Register. The risk of autism in the group of vaccinated children was the same as that in unvaccinated children. Furthermore, development of autism was not associated with: 

  • Their age at the time of vaccination
  • The time since vaccination
  • The date of vaccination and the diagnosis of autism

Subsequent studies and meta-analysis have corroborated the findings that the MMR vaccine does not cause autism.

Watch as Dr. Offit talks about vaccines and autism in this short video, part of the Talking about Vaccines with Dr. Paul Offit video series.

  • Do vaccines cause autism?

    Paul Offit, MD: Hi, my name is Paul Offit. I’m talking to you today from the Vaccine Education Center at the Children’s Hospital of Philadelphia.

    I think probably one of the most common concerns parents have about vaccines is, do they cause autism? Certainly, very easy to find that contention on the internet and in chat rooms, so it can be scary. And I think from the parents’ stand point, they argue this, “Look, my child was fine, they got a vaccine, now they've developed signs and symptoms of autism. Could the vaccine have done it?”

    Well, the good news is that’s an answerable question. And it’s really been in three different areas that this issue has been raised. One is the concern that the combination measles-mumps-rubella, or MMR, vaccine caused autism. The second is the notion that there was an ethyl-mercury containing preservative that was in a number of vaccines, now it’s only in some multi-dose vials of influenza vaccine, called thimerosal. And the third sort of concern is that children are just getting too many vaccines too soon, that that’s somehow weakening, or overwhelming, or perturbing their immune system. Well, these are studiable questions; you can answer this question. So, for example in the case of measles, mumps and rubella, there now have been 18 studies done in seven different countries, on three different continents, involving hundreds of thousands of children who either did or didn’t get the MMR vaccine, making sure that those two groups are otherwise similar with regard to their healthcare-seeking behavior, their socioeconomic background, their medical background, and again, and again, and again those studies all found the same thing — that the MMR vaccine did not cause autism, and that’s been true also for these other two concerns.

    The good news is I think most parents get this. I think most parents believe these studies because a recent study by the Autism Science Foundation found that about 85% of parents of children with autism now are comfortable that vaccines weren’t the cause.

    Thank you.

Transcript Transcript

A note about acetaminophen

Acetaminophen is an over-the-counter medication used to relieve pain and reduce fever. It is one of the few pain-relieving medications that a woman can use during pregnancy. While some studies have suggested a relationship between use of this medication in pregnancy and neurodevelopmental conditions after birth, most studies have not found this link. In fact, the largest and best-controlled studies do not find any association regardless of when during pregnancy the medication is used. For example, large studies from both Sweden and Japan compared the risk for autism in siblings who were or were not exposed to acetaminophen during pregnancy, and neither found an association between exposure and later development of autism. 

On the other hand, if a woman has a high (more than 103 degrees Fahrenheit) or prolonged fever during pregnancy, the developing baby can suffer negative outcomes, including: 

  • Birth defects of the brain and spinal cord
  • Autism
  • Cleft lip
  • Heart defects
  • Preterm delivery
  • Miscarriage 

For these reasons, in some cases, it is important to use acetaminophen to control fever. 

Pregnant women should talk with their doctors about whether, when and how much of any medication to take during pregnancy .

In 2025, officials in the federal government suggested that acetaminophen is a cause of autism. The data they relied on were from limited studies that are not considered to represent the overwhelming body of evidence. For these reasons, scientists who study autism and professional organizations representing clinicians who care for pregnant women and children quickly released statements highlighting what the science tells us and why the suggestions to avoid acetaminophen can be dangerous. For more information on this topic, please check:

References

DeStefano, R., T.T. Shimabukuro. The MMR vaccine and autism, Ann Rev Virol (2019) 6: 1.1-1.16.
Autism is a developmental disability that can cause significant social, communication, and behavioral challenges. A report published in 1998, but subsequently retracted by the journal, suggested that measles, mumps, and rubella (MMR) vaccine causes autism. However, autism is a neurodevelopmental condition that has a strong genetic component with genesis before one year of age, when MMR vaccine is typically administered.

Hviid A, Hansen JV, Frisch M, Melbye M. Measles, mumps, rubella vaccination and autism. Ann Int Med 2019; epub ahead of print.
The authors evaluated the relationship between receipt of MMR vaccine and the development of autism in more than 650,000 Danish children born between 1999 and 2010. During the study period, about 6,500 children were diagnosed with autism. The authors found no increased risk of autism in those who received one or two doses of MMR vaccine compared with those who didn’t. The authors also found that MMR vaccine did not increase the risk of autism in children with specific risk factors such as maternal age, paternal age, smoking during pregnancy, method of delivery, gestational age, 5-minute APGAR scores, low birthweight, head circumference, and sibling history of autism. Further, by evaluating specific time periods after vaccination, the authors found no evidence for a regressive phenotype triggered by vaccination. The authors concluded that MMR vaccination did not increase the risk for autism or trigger autism in susceptible children.

Jain A, Marshall J, Buikema A, et al. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA 2015;313(15):1534-1540.
The authors evaluated about 100,000 younger siblings who did or did not receive an MMR vaccine when the older sibling had been diagnosed with autism spectrum disorder (ASD). For children with or without older siblings with ASD, there were no differences in the adjusted relative risks of ASD between no doses of MMR, one dose of MMR or two doses of MMR. The authors concluded that receipt of MMR vaccine was not associated with increased risk of ASD even among children whose older siblings had ASD, and, therefore, were presumed to be at higher risk for developing this disorder.

Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 2014;32:3623-3629.

The authors conducted a meta-analysis of case-control and cohort studies that examined the relationship between the receipt of vaccines and development of autism. Five cohort studies involving more than 1.2 million children and five case-control studies involving more than 9,000 children were included in the analysis. The authors concluded that vaccinations, components of vaccines (thimerosal), and combination vaccines (MMR) were not associated with the development of autism or autism spectrum disorder.

Hornig M, Briese T, Buie T, et al. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS ONE 2008;3(9):e3140.
The authors evaluated children with GI disturbances with and without autism to determine if those with autism were more likely to have measles virus RNA or inflammation in bowel tissues and to determine if autism or GI symptoms related temporally to receipt of MMR.  The authors found no differences between patients with and without autism relative to measles virus presence in the ileum and cecum or GI inflammation. GI symptoms and autism onset were unrelated to the receipt of MMR vaccine.

Uchiyama T, Kurosawa M, Inaba Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord 2007;37:210-217.
MMR vaccination was only utilized in Japan between 1989 and 1993, given as a single dose between 12 and 72 months of age.  The authors examined the rate of autism spectrum disorders (ASD) involving regressive symptoms in children who did or didn’t receive MMR during that period. No significant differences were found in the incidence of ASD regression between those who did or didn’t receive an MMR vaccine.

Afzal MA, Ozoemena LC, O’Hare A, et al. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 2006;78:623-630.
Investigators obtained blood from 15 children diagnosed with autism with developmental regression and a documented previous receipt of MMR vaccine. Measles virus genome was not present in any of the samples tested. The authors concluded that measles vaccine virus was not present in autistic children with developmental regression.

Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 2005;46(6):572-579.
MMR vaccination was only utilized in Japan between 1989 and 1993, given as a single dose between 12 and 72 months of age. The authors found that while MMR vaccination rates declined significantly in the birth cohort of years 1988 through 1992 (~70% in 1988, < 30% in 1991 and < 10% in 1992), the cumulative incidence of ASD up to age 7 years increased significantly. The authors concluded that withdrawal of MMR in countries where it is still being used will not lead to a reduction in the incidence of ASD.

Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: a case-control study. The Lancet 2004;364:963-969.
The authors reviewed a major United Kingdom database for patients diagnosed with autism or other pervasive developmental disorders (PDD) over a 28-year period and similarly aged patients without those diagnoses to determine if the receipt of MMR vaccination was associated with an increased risk of autism or other PDD. They found no association between MMR vaccine and risk of autism or other PDD.

Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347(19):1477-1482.
The authors conducted a retrospective review of all children (> 500,000) born in Denmark between 1991 and 1998 to determine if a link existed between receipt of MMR vaccine and diagnosis of autism or autism spectrum disorders. No association was found between ages at the time of vaccination, the time since vaccination, or the date of vaccination and the development of autistic disorder.

Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. The Lancet 1999;353:2026-2029.
The authors determined whether the introduction of MMR vaccine in the United Kingdom in 1988 affected the incidence of autism by examining children born between 1979 and 1998. They found no sudden change in the incidence of autism after introduction of MMR vaccine and no association between receipt of the vaccine and development of autism.

Ahlqvist VH, Sjoqvist H, et al. Acetaminophen use during pregnancy and children’s risk of autism, ADHD, and intellectual disability. JAMA 2024;331(14): 1205-1214.
The authors evaluated almost 2.5 million Swedish children to compare the risk for autism, attention deficit hyperactivity disorder (ADHD) and intellectual disability among those exposed to acetaminophen before birth (185,909) and those who were not. To control for potential confounding factors, the scientists compared the risk between siblings who were or were not exposed and found no association. Likewise, the authors compared relative quantities of exposures among siblings to evaluate whether there was any sign of increasing risk with increasing exposure, and they did not find evidence of a dose-response either.

Okubo Y, Hayakawa I, et al. Maternal acetaminophen use and offspring’s neurodevelopmental outcome: A nationwide birth cohort study. Paediatr Perinat Epidemiol 2026;40:70-79.
The authors examined the records of over 217,000 children in Japan to determine whether use of acetaminophen during pregnancy was associated with diagnosis of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) or intellectual disabilities in the children. About 40% of the children (85,853) were exposed to acetaminophen during the fetal period. While rates of these conditions were slightly higher compared with matched controls not exposed to acetaminophen, when the authors compared sibling controls (to account for confounding factors), the associations went away. Similarly, when the authors took into account exposure misclassifications (e.g., use of over-the-counter acetaminophen), live-birth bias and negative exposure controls, the association went away suggesting that the associations found in the initial analysis may have resulted from confounding factors rather than represent an actual association.

Reviewed by Paul Offit, MD, on Nov. 9, 2026

Jump back to top